Therapy of alveococcosis in man.

J Int Med Res

Published: December 1977

Diagnostic, therapeutic and prognostic aspects are interpreted on the basis of two cases of Echinococcus alveolaris. Both patients had undergone partial hepatectomy and were subsequently treated chemotherapeutically. In one case dehydroemetine and mebendazole (Vermox, Janssen), and in the other case metrifonate (Bilarcil, Bayer A.G.) were used. The diagnosis of alveococcosis of the liver was demonstrated in one case histologically on the occasion of appendectomy, and in the other case by the indirect immunofluorescence test and passive haemagglutination. In case of suspected alveococcosis these serological are imperative, as they are the most reliable methods of demonstrating this disease. The latest trend in theraphy aims at a combination of surgery and chemotherapy. Mebendazole seems to be promising as an anthelmintic agent for the treatment of alveococcosis. Remission of the disease was obtained in either case.

Download full-text PDF

Source
http://dx.doi.org/10.1177/030006057700500513DOI Listing

Publication Analysis

Top Keywords

case
6
therapy alveococcosis
4
alveococcosis man
4
man diagnostic
4
diagnostic therapeutic
4
therapeutic prognostic
4
prognostic aspects
4
aspects interpreted
4
interpreted basis
4
basis cases
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!